These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4730838)

  • 1. Dose-dependent enzyme induction.
    Breckenridge A; Davies DS; Davies L; Orme M
    Br J Pharmacol; 1973 Mar; 47(3):616P-617P. PubMed ID: 4730838
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-dependent enzyme induction.
    Breckenridge A; Orme ML; Davies L; Thorgeirsson SS; Davies DS
    Clin Pharmacol Ther; 1973; 14(4):514-20. PubMed ID: 4723259
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical implications of enzyme induction.
    Breckenridge A; Orme M
    Ann N Y Acad Sci; 1971 Jul; 179():421-31. PubMed ID: 5285387
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of physicochemical and pharmacokinetic properties of barbiturates on the induction of drug metabolism.
    Pelkonen O; Kärki NT
    Chem Biol Interact; 1973 Aug; 7(2):93-9. PubMed ID: 4766941
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzyme induction in sheep: effects of phenobarbital on in vivo and in vitro drug metabolism.
    Shetty SN; Himes JA; Edds GT
    Am J Vet Res; 1972 May; 33(5):935-42. PubMed ID: 4112405
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies in mice on the effectiveness of various methods of enzyme induction with phenobarbital].
    Buzello W; Scholler KL; Schöppe B
    Arzneimittelforschung; 1973 Sep; 23(9):1337-9. PubMed ID: 4801232
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in liver blood flow during enzyme induction.
    Ohnhaus EE; Thorgeirsson SS; Davies DS; Breckenridge A
    Biochem Pharmacol; 1971 Oct; 20(10):2561-70. PubMed ID: 5114497
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine inhibition of hepatic drug metabolism: evidence for a competitive mechanism.
    Louis-Ferdinand RT; Fuller GC; Lal H
    Clin Toxicol; 1972; 5(3):387-93. PubMed ID: 5073822
    [No Abstract]   [Full Text] [Related]  

  • 10. The expanding role of microsomal enzyme induction, and its implications for clinical chemistry.
    Goldberg DM
    Clin Chem; 1980 May; 26(6):691-9. PubMed ID: 6989516
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of drug metabolizing enzymes in man and rat by dichloralphenazone.
    Breckenridge A; Orme ML; Davies DS; Thorgeirsson S
    Clin Sci; 1969 Oct; 37(2):565. PubMed ID: 5359008
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in microsomal enzyme induction between Sprague-Dawley and Long-Evans rats.
    Jori A; Pugliatti C; Santini V
    Pharmacology; 1972; 7(5):296-304. PubMed ID: 4644000
    [No Abstract]   [Full Text] [Related]  

  • 13. [Enzyme induction in the liver].
    Niederland TR
    Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):102-5. PubMed ID: 1021374
    [No Abstract]   [Full Text] [Related]  

  • 14. 14C-antipyrine as a model compound in the study of drug oxidation and enzyme induction in individual surviving rats.
    Bakke OM; Bending M; Aarbakke J; Davies DS
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):91-7. PubMed ID: 4479350
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic studies on tolerance to multiple doses of sedative--hypnotics in a polydrug abuse population. II. Secobarbital--amobarbital.
    Faulkner TP; McGinity JW; Hayden JH; Olson DA; Comstock EG
    J Clin Pharmacol; 1979 Oct; 19(10):605-16. PubMed ID: 512058
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in plasma -glutamyl transpeptidase activity associated with alterations in drug metabolism in man.
    Whitfield JB; Moss DW; Neale G; Orme M; Breckenridge A
    Br Med J; 1973 Feb; 1(5849):316-8. PubMed ID: 4405530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lipid ingestion on the induction of drug metabolizing enzymes of nuclear envelope and microsomes by phenobarbital.
    Cheng KC; Ragland WL; Wade AE
    J Environ Pathol Toxicol; 1980 Aug; 4(1):219-35. PubMed ID: 7441111
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interactions between phenprocoumon (Marcumar) and drug-catabolizing, enzyme system-inducing pharmaceutic agents].
    Heni N; Völger R; Glogner P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1579-82. PubMed ID: 347786
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic control of drug levels and of the induction of drug-metabolizing enzymes in man: individual variability in the extent of allopurinol and nortriptyline inhibition of drug metabolism.
    Vesell ES; Passananti GT; Greene FE; Page JG
    Ann N Y Acad Sci; 1971 Jul; 179():752-73. PubMed ID: 4105797
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
    Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
    J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.